Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russek, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russek, H. I.
(Chest. 1963;43:541-543.)
© 1963 American College of Chest Physicians

Present Status of Anticoagulant Therapy in Acute Myocardial Infarction

Henry I. Russek M.D., F.C.C.P.1

1 U. S. Public Health Service Hospital

Anticoagulants, like other drugs, should be used only under certain well-defined circumstances. In acute myocardial infarction, the initial clinical appearance of the patient, irrespective of age, constitutes the best index to his future course and the deciding factor regarding the need for anticoagulants. The physician's knowledge of the life history of this disease and of the limitations and dangers of thromboprophylactic therapy has progressed sufficiently to warrent individual selection of cases for treatment on the basis of established clinical criteria.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1963 by the American College of Chest Physicians.